Loading...
XKRX036220
Market cap131mUSD
Jan 07, Last price  
12,960.00KRW
1D
-7.89%
1Q
1.41%
IPO
-67.62%
Name

Osang HealthCare Co Ltd

Chart & Performance

D1W1MN
XKRX:036220 chart
P/E
P/S
EPS
7,878.28
Div Yield, %
13.23%
Shrs. gr., 5y
1.34%
Rev. gr., 5y
44.67%
Revenues
355.85b
+83.53%
59,073,745,85254,339,923,23056,145,505,37157,268,998,638257,967,344,456132,326,879,204193,893,072,828355,846,882,560
Net income
116.44b
+186.46%
-10,901,034,2478,848,437,7482,146,291,155-4,224,368,776124,996,259,1501,460,426,01040,646,921,170116,435,775,510
CFO
152.60b
+260.29%
3,093,067,781-460,330,576971,802,0335,293,698,350101,161,764,56210,807,351,78642,353,497,355152,595,520,040

Profile

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang, South Korea.
IPO date
Jun 05, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT